The long-range goal of this project is to understand the transforming interactions between DNA tumor virus and target cells. The approach has been to define molecular interactions and biological functions expressed by the SV40 transforming protein, large tumor antigen (T-ag). There is evidence for multiple effects exerted by distinct T-ag subpopulations on transformed cells, including possible role for plasma-membrane-associated T-ag (pmT-ag). This renewal application focuses on questions fundamental to understanding the molecular mechanisms of SV40 carcinogenesis. This program will correlate T-ag structure and function with transformation events. The following specific aims are present. (1) The structure and function of SV40 T-ag containing, membrane-associated protein complexes will be analyzed. We have developed a butane extraction method that selectively recovers membrane protein complexes that contain pmT-ag and p53-related protein (p56). Other cellular components in the complexes (60K, 50K, 45K, 35K) will be identified; it is hypothesized they are members of a receptor complex. the composition modifications, and biochemical activities of pmT-ag-containing complexes will be investigated . Possible involvement of T-ag in a growth-factor-like pathway will be examined. (2) Transformation phenotypes of new in-phase deletion mutants will be related to specific interactions of mutant T-89 with cellular proteins and the plasma membrane. Different assays will distinguish T-ag domain required for cell immortalization and phenotypic transformation. Complementation transformation tests may permit assignment of T-ag functions to categories defined by known oncogenes. Mutant T-ag polypeptides will be characterized structurally and biochemically, including complex formation with membrane proteins, and those analyses correlated with transformation by the mutants. (3)Trafficking of SV40 T- ag to the cell surface will be studied. Deletion mutants will reveal possible effects of the short hydrophobic sequence in T-ag on transport and membrane interaction. The potential involvement of cellular heat- shock protein p73 (that bind T-ag) in pmT-ag transport will be addressed. A role for O-glycosylation o T-ag in trafficking or membrane association will be considered. (4) Cellular and molecular events involved in muoti- stage carcinogenesis in livers of SV40 transgenic mice will be defined. We have found that mice with the WT T-ag gene controlled by the alpha-1- antitrypsin promoter develop liver tumors. New transgenic mice carrying the p53 or mutants T-ag genes will be made. Various transgenic lines will be crossed and pathology in progeny animal determined. The expression of viral (pmT-ag and cellular (oncogenes) events will be correlated with different stages of neoplastic progression. Hyperplastic liver cells will be cultured to determine in vitro growth properties that correspond to preneoplasia in vivo.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA022555-13
Application #
3165851
Study Section
Virology Study Section (VR)
Project Start
1978-01-01
Project End
1994-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
13
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Lednicky, J A; Jafar, S; Wong, C et al. (1997) High-fidelity PCR amplification of infectious copies of the complete simian virus 40 genome from plasmids and virus-infected cell lysates. Gene 184:189-95
Lednicky, J A; Butel, J S (1997) Tissue culture adaptation of natural isolates of simian virus 40: changes occur in viral regulatory region but not in carboxy-terminal domain of large T-antigen. J Gen Virol 78 ( Pt 7):1697-705
Lednicky, J A; Butel, J S (1997) A coupled PCR and restriction digest method for the detection and analysis of the SV40 regulatory region in infected-cell lysates and clinical samples. J Virol Methods 64:1-9
Lednicky, J A; Stewart, A R; Jenkins 3rd, J J et al. (1997) SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes. Int J Cancer 72:791-800
Stewart, A R; Lednicky, J A; Benzick, U S et al. (1996) Identification of a variable region at the carboxy terminus of SV40 large T-antigen. Virology 221:355-61
Lednicky, J A; Garcea, R L; Bergsagel, D J et al. (1995) Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology 212:710-7
Lednicky, J A; Wong, C; Butel, J S (1995) Artificial modification of the viral regulatory region improves tissue culture growth of SV40 strain 776. Virus Res 35:143-53
Sawai, E T; Rasmussen, G; Butel, J S (1994) Construction of SV40 deletion mutants and delimitation of the binding domain for heat shock protein to the amino terminus of large T-antigen. Virus Res 31:367-78
Fromm, L; Shawlot, W; Gunning, K et al. (1994) The retinoblastoma protein-binding region of simian virus 40 large T antigen alters cell cycle regulation in lenses of transgenic mice. Mol Cell Biol 14:6743-54
Sawai, E T; Butel, J S (1992) Epitope mapping and conformational analysis of SV40 T-antigen deletion mutants. Virology 189:782-5

Showing the most recent 10 out of 31 publications